HomeInsightsEPS

Glenmark Life Sciences Ltd EPS

Glenmark Life Sciences Ltd EPS

stocks purchased

₹ 0.4 Cr

Volume Transacted

(Jan 15, 2025)

stocks purchased

3.5 K

Stocks Traded

(Jan 15, 2025)

Last Updated on: Jan 15, 2025

Image

Glenmark Life Sciences Ltd

NSE: GLS

EPS

₹ 34.56

Last updated on: Jan 14, 2025

Key Highlights

  • The Earning per Share of Glenmark Life Sciences Ltd is ₹ 34.56 as of 14 Jan 25 .
  • The earning per share of Glenmark Life Sciences Ltd changed from ₹ 11.05 to ₹ 7.78 over 6 quarters. This represents a CAGR of -20.86% .

Historical Earning per Share of Glenmark Life Sciences Ltd

No data available

* All values are in

Company Fundamentals for Glenmark Life Sciences Ltd

Market Cap

12,508 Cr

EPS

34.6

P/E Ratio (TTM) *

29.5

P/B Ratio (TTM) *

4.9

Day’s High *

1052.0

Day’s Low

1004.85

DTE *

0.0

ROE *

16.7

52 Week High

1335.0

52 Week Low

666.05

ROCE *

22.3

Market Price of Glenmark Life Sciences Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20251020.8
13 Jan 2025984.5
10 Jan 20251011.1
09 Jan 20251029.35
08 Jan 20251041.7
07 Jan 20251041.15
06 Jan 20251003.6
03 Jan 20251029.65
02 Jan 20251029.65
01 Jan 20251016.35

SWOT Analysis Of Glenmark Life Sciences Ltd

Strength

2

S

Weakness

2

W

Opportunity

1

O

Threats

0

T

BlinkX Score for Glenmark Life Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Glenmark Life Sciences Ltd

Market Value

12,508

Asset Value

1,921

5.5 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Glenmark Life Sciences Ltd3412,508
Sun Pharmaceuticals Industries Ltd464,24,382
Divis Laboratories Ltd691,59,224
Cipla Ltd571,16,943
Dr Reddys Laboratories Ltd631,11,588
Mankind Pharma Ltd511,10,215

Historical Market Cap of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Historical Revenue of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Historical EBITDA of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Historical Net Profit of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Glenmark Life Sciences Ltd News Hub

News

Glenmark Life Sciences renamed Alivus Life Sciences

Glenmark Life Sciences has been renamed Alivus Life Sciences with effect from 17 December ...

Read more

17 Dec 2024 19:43

News

Glenmark Life drops after PAT slides 20% YoY to Rs 95 crore in Q2

Profit before tax (PBT) dropped 19.8% YoY to Rs 127.46 crore in the quarter ended 30 Septe...

Read more

25 Oct 2024 12:45

News

Glenmark Life Sciences announces board meeting date

Glenmark Life Sciences will hold a meeting of the Board of Directors of the Company on 24 ...

Read more

17 Oct 2024 17:07

News

Glenmark Life Sciences AGM scheduled

Glenmark Life Sciences announced that the Annual General Meeting (AGM) of the company will...

Read more

06 Sep 2024 16:35

News

Glenmark Life Sciences Ltd leads gainers in 'A' group

Tamilnad Mercantile Bank Ltd, Marico Ltd, Rossari Biotech Ltd and Nestle India Ltd are amo...

Read more

05 Aug 2024 12:00

News

Glenmark Life drops after Q1 PAT slides 18% YoY to Rs 111 cr

Revenue from operations rose 1.75% YoY to Rs 588.62 crore in the first quarter of FY25. Pr...

Read more

26 Jul 2024 12:21

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Glenmark Life Sciences Ltd

What is the EPS of Glenmark Life Sciences Ltd stock?

The Earnings Per Share (EPS) of Glenmark Life Sciences Ltd is 34.56. An EPS is the amount of net income attributed to each share of a common stock.

How is Glenmark Life Sciences Ltd EPS calculated?

The EPS of Glenmark Life Sciences Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Glenmark Life Sciences Ltd report its EPS?

Glenmark Life Sciences Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Glenmark Life Sciences Ltd EPS?

Factors that influence the EPS of Glenmark Life Sciences Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Glenmark Life Sciences Ltd EPS growth indicate future performance?

Yes, consistent growth in Glenmark Life Sciences Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions